These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
397 related items for PubMed ID: 16112397
1. The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions. Broccardo M, Linari G, Guerrini R, Agostini S, Petrella C, Improta G. Peptides; 2005 Sep; 26(9):1590-7. PubMed ID: 16112397 [Abstract] [Full Text] [Related]
2. Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor. Peng YL, Chang M, Dong SL, Li W, Han RW, Fu GX, Chen Q, Wang R. Regul Pept; 2006 May 15; 134(2-3):75-81. PubMed ID: 16516988 [Abstract] [Full Text] [Related]
3. The gastric effects of UFP-112, a new nociceptin/orphanin receptor agonist, in physiological and pathological conditions. Broccardo M, Guerrini R, Morini G, Polidori C, Agostini S, Petrella C, Improta G. Peptides; 2007 Oct 15; 28(10):1974-81. PubMed ID: 17765363 [Abstract] [Full Text] [Related]
4. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor. Carrà G, Rizzi A, Guerrini R, Barnes TA, McDonald J, Hebbes CP, Mela F, Kenigs VA, Marzola G, Rizzi D, Gavioli E, Zucchini S, Regoli D, Morari M, Salvadori S, Rowbotham DJ, Lambert DG, Kapusta DR, Calo' G. J Pharmacol Exp Ther; 2005 Mar 15; 312(3):1114-23. PubMed ID: 15509719 [Abstract] [Full Text] [Related]
10. Regulation of pancreatic secretion in vitro by nociceptin/orphanin FQ and opioid receptors: a comparative study. Linari G, Agostini S, Broccardo M, Petrella C, Improta G. Pharmacol Res; 2006 Nov 28; 54(5):356-60. PubMed ID: 16979347 [Abstract] [Full Text] [Related]
11. Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity. Guerrini R, Carra' G, Calo' G, Trapella C, Marzola E, Rizzi D, Regoli D, Salvadori S. J Pept Res; 2004 Jun 28; 63(6):477-84. PubMed ID: 15175020 [Abstract] [Full Text] [Related]
12. UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor. Calo G, Guerrini R, Rizzi A, Salvadori S, Burmeister M, Kapusta DR, Lambert DG, Regoli D. CNS Drug Rev; 2005 Jun 28; 11(2):97-112. PubMed ID: 16007234 [Abstract] [Full Text] [Related]
13. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor. Rizzi A, Spagnolo B, Wainford RD, Fischetti C, Guerrini R, Marzola G, Baldisserotto A, Salvadori S, Regoli D, Kapusta DR, Calo G. Peptides; 2007 Jun 28; 28(6):1240-51. PubMed ID: 17532097 [Abstract] [Full Text] [Related]
14. [Nphe1,Arg14,Lys15]N/OFQ-NH2 is a competitive antagonist of NOP receptors in the periaqueductal gray. Chiou LC, Liao YY, Guerrini R, Calo' G. Eur J Pharmacol; 2005 May 16; 515(1-3):47-53. PubMed ID: 15896734 [Abstract] [Full Text] [Related]
15. Nociceptin/orphanin FQ inhibits electrically induced contractions of the human bronchus via NOP receptor activation. Basso M, Risse PA, Naline E, Calo G, Guerrini R, Regoli D, Advenier C. Peptides; 2005 Aug 16; 26(8):1492-6. PubMed ID: 16042989 [Abstract] [Full Text] [Related]
16. Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation. Trombella S, Vergura R, Falzarano S, Guerrini R, Calo G, Spisani S. Peptides; 2005 Aug 16; 26(8):1497-502. PubMed ID: 15922491 [Abstract] [Full Text] [Related]